CAS 37762-06-4
:Zaprinast
Description:
Zaprinast is a chemical compound known for its role as a selective inhibitor of phosphodiesterase type 5 (PDE5), which is an enzyme that breaks down cyclic guanosine monophosphate (cGMP). By inhibiting this enzyme, Zaprinast increases the levels of cGMP, leading to vasodilation and enhanced blood flow, particularly in the pulmonary and systemic circulation. This property makes it of interest in the treatment of conditions such as pulmonary hypertension. Zaprinast is characterized by its molecular structure, which includes a pyrimidine ring and a nitro group, contributing to its biological activity. The compound is typically administered in research settings to study its effects on vascular smooth muscle relaxation and other physiological processes. Additionally, Zaprinast has been investigated for its potential neuroprotective effects and its role in various signaling pathways. As with many pharmacological agents, the safety profile and potential side effects are important considerations in its use.
Formula:C13H13N5O2
InChI:InChI=1S/C13H13N5O2/c1-2-7-20-9-6-4-3-5-8(9)11-14-12-10(13(19)15-11)16-18-17-12/h3-6H,2,7H2,1H3,(H2,14,15,16,17,18,19)
InChI key:InChIKey=REZGGXNDEMKIQB-UHFFFAOYSA-N
SMILES:O(CCC)C1=C(C=CC=C1)C=2NC3=C(C(=O)N2)NN=N3
Synonyms:- 1,4-Dihydro-5-(2-propoxyphenyl)-1,2,3-triazolo(4,5-d)pyrimidin-7-one
- 2-(2-Propoxyphenyl)-8-aza-6-purinone
- 2-(o-Propoxyphenyl)-8-azapurin-6-one
- 2-o-Propoxyphenyl-8-azapurin-6-on
- 2-o-Propoxyphenyl-8-azapurine-6-one
- 3,6-Dihydro-5-(2-propoxyphenyl)-7H-(1,2,3)truaziki(4,5-d)pyrimidin-7-on
- 3,6-Dihydro-5-(2-propoxyphenyl)-7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one
- 3,6-Dihydro-5-(o-propoxyphenyl)-7H-v-triazolo(4,5-d)pyrimidin-7-one
- 5-(2-Propoxyphenyl)-1H-[1,2,3]triazolo[4,5-d]pyrimidin-7(4H)-one
- 5-(2-propoxyphenyl)-2,3-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one
- 6,7-Dihydro-5-(2-propoxyphenyl)-1H-triazolo(4,5-d)pyrimidin-7-on
- 6,7-Dihydro-5-(2-propoxyphenyl)-1H-triazolo(4,5-d)pyrimidin-7-on [IUPAC]
- 7H-1,2,3-Triazolo(4,5-d)pyrimidin-7-one, 1,4-dihydro-5-(2-propoxyphenyl)-
- 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 3,6-dihydro-5-(2-propoxyphenyl)-
- 8-Aza-2-(2-propoxyphenyl)-6-purinone
- M and B 22948
- M&B 22,948
- Unii-Gxt25D5Ds0
- Zaprinast [INN:BAN]
- Zaprinastum
- Zaprinastum [INN-Latin]
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.
Zaprinast
CAS:<p>Zaprinast is a cGMP-selective phosphodiesterase (PDE) inhibitor and a GPR35 agonist.</p>Formula:C13H13N5O2Purity:99.73% - 99.77%Color and Shape:White To Off White PowderMolecular weight:271.27Zaprinast
CAS:<p>M02689 - Zaprinast</p>Formula:C13H13N5O2Purity:>99%Color and Shape:SolidMolecular weight:271.28Zaprinast
CAS:Controlled Product<p>Applications A selective inhibitor of cyclic-GMP phosphodiesterase (PDE V, calmodulin insensitive). Since cGMP mediates the vasorelaxant action of nitric oxide, as well as the natriuretic and diuretic effect of atrial natriuretic factor (ANF) through the activation of PKG (cGMP dependent protein kinase), such inhibitors may display vasodilating, relaxant, and diuretic effects. These compounds may prove useful in treating hypertension and congestive heart failure.<br>References Burns, F., et al.: Biochem. J., 238, 487 (1992), Lugnier, C., et al.: Am. J. Physiol., 262, H654 (1992),<br></p>Formula:C13H13N5O2Color and Shape:NeatMolecular weight:271.27Zaprinast
CAS:<p>Phosphodiesterase (PDE5, 6, 9 and 11) inhibitor</p>Formula:C13H13N5O2Purity:Min. 95%Color and Shape:Pink To Light (Or Pale) Tan SolidMolecular weight:271.27 g/mol







